How Is The Market Feeling About Lucid Diagnostics Inc. – Common Stock?
Lucid Diagnostics Inc. - Common Stock's (NASDAQ:LUCD) short percent of float has fallen 4.35% since its last report. The company recently reported that it has 378.70 thousand shares sold short, which is 6.6% of all regular shares that are available for trading.
Lucid Diagnostics Q4 Adj. EPS $(0.22) Down From $(0.19) YoY, Sales $300.00K
Lucid Diagnostics (NASDAQ:LUCD) reported quarterly losses of $(0.22) per share. This is a 15.79 percent decrease over losses of $(0.19) per share from the same period last year. The company reported $300.00 thousand in
PAVmed Subsidiary Lucid Diagnostics Launches Lucid Test Centers In Seattle, Portland And Boise
NEW YORK--(BUSINESS WIRE)-- Lucid Diagnostics Inc. (NASDAQ:LUCD) (“Lucid”), a commercial-stage cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (NASDAQ:PAVM, PAVMZ))
12 Health Care Stocks Moving In Friday’s After-Market Session
Gainers
Avinger (NASDAQ:AVGR) stock moved upwards by 9.7% to $0.34 during Friday's after-market session. This security traded at a volume of 1.2 million shares come close, making up 60.0% of its average volume over the last 100 days. The company's market cap stands at $32.6 million.
